Holt-Oram Syndrome With Atrial Septal Defect
- PMID: 39156428
- PMCID: PMC11329708
- DOI: 10.7759/cureus.64772
Holt-Oram Syndrome With Atrial Septal Defect
Abstract
Holt-Oram syndrome is an autosomal dominant condition marked by heart and upper limb defects. Holt and Oram were the first to narrate this in 1960. Holt-Oram syndrome is the prototype of heart-hand syndromes and has recently been mapped to the long arm of chromosome 12 (12q2). This syndrome was described in 1960 by Dr Mary Holt and Dr Samuel Oram. It is an autosomal dominant condition resulting from a mutation in TBX5 located on chromosome 12q24.1, which regulates cardiac and limb morphogenesis. It must be differentiated from heart-hand syndrome type II (Tobatznik's syndrome) and heart-hand syndrome type III (MIM No. 140450), which are phenotypically similar. The latter do not map to 12q2, and atrial septal defects do not occur in these conditions. This syndrome is distinguished by heart problems as well as thumb aplasia or hypoplasia. It is sometimes referred to as atriodigital syndrome, upper limb-cardiovascular syndrome, heart-hand syndrome, cardiomelic syndrome, or cardiac limb syndrome. Other upper-limb anomalies include aplasia or hypoplasia of the radius, arm length variation, atypical forearm pronation and supination, uncommon thumb resistance, sloping shoulders, and restricted shoulder movement. All those who are affected have an aberrant carpal bone, which might be the only sign of the illness. Seventy-five percent of those with Holt-Oram syndrome have a congenital cardiac defect, which most frequently affects the septum. In this case, we report a girl who is 4 years and 6 months old and is a known case of Holt-Oram syndrome with an atrial septal defect. She underwent device closure and had come to the pediatric op with fever and cough.
Keywords: asd; autosomal dominant; genetic; left thumb hypoplasia; sporadic; tbx5.
Copyright © 2024, C.S et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Postma AV, van de Meerakker JB, Mathijssen IB, et al. Circ Res. 2008;102:1433–1442. - PubMed
-
- The cross sectional anatomy of ventricular septal defects: a reappraisal. Baker EJ, Leung MP, Anderson RH, Fischer DR, Zuberbuhler JR. https://heart.bmj.com/content/59/3/339. Br Heart J. 1988;59:339–351. - PMC - PubMed
-
- TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Mori AD, Bruneau BG. Curr Opin Cardiol. 2004;19:211–215. - PubMed
-
- TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts. Reamon-Buettner SM, Borlak J. Hum Mutat. 2004;24:104. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous